The "Therapeutic Window" of the "Atypical" Antipsychotic Paliperidone ER-A Positron Emission Tomography Study With [18F]Fallypride as the Radiotracer.
Phase of Trial: Phase IV
Latest Information Update: 08 Apr 2014
At a glance
- Drugs Paliperidone (Primary) ; Risperidone (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Janssen-Cilag
- 07 Jun 2017 Biomarkers information updated
- 21 Jul 2012 New source identified and integrated (European Clinical Trials Database record; EudraCT2008-003340-11).
- 18 May 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.